Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:PAND

Pandion Therapeutics (PAND) Stock Price, News & Analysis

Pandion Therapeutics logo

About Pandion Therapeutics Stock (NASDAQ:PAND)

Advanced Chart

Key Stats

Today's Range
$60.05
$60.05
50-Day Range
$59.90
$60.28
52-Week Range
$10.28
$62.90
Volume
N/A
Average Volume
355,921 shs
Market Capitalization
$1.77 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive PAND Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pandion Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

PAND Stock News Headlines

Jeff Brown: My shocking meeting in Washington, D.C.
President Trump’s “Project MAFA” After a shocking discovery in Washington D.C., Jeff Brown is putting out an urgent broadcast on Wednesday, July 16, at 8 p.m. ET to cover the president’s bold new initiative. Get a look inside Trump’s genius masterplan to create a “new” gold standard, smash the U.S. debt, and kick off a Golden Century before July 25.
Lawsuits News | Today's Latest Stories | Reuters
Pandion Therapeutics, Inc.
See More Headlines

PAND Stock Analysis - Frequently Asked Questions

Pandion Therapeutics, Inc. (NASDAQ:PAND) issued its quarterly earnings data on Monday, November, 16th. The company reported ($0.51) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.44) by $0.07. The company had revenue of $2.63 million for the quarter, compared to analysts' expectations of $1 million.

Pandion Therapeutics (PAND) raised $94 million in an initial public offering (IPO) on Friday, July 17th 2020. The company issued 5,500,000 shares at a price of $16.00-$18.00 per share. Goldman Sachs, Morgan Stanley, SVB Leerink and BMO Capital Markets acted as the underwriters for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that Pandion Therapeutics investors own include Sorrento Therapeutics (SRNE), Advanced Micro Devices (AMD), Dynavax Technologies (DVAX), eBay (EBAY), Garmin (GRMN) and JD.com (JD).

Company Calendar

Last Earnings
11/16/2020
Today
7/14/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:PAND
CIK
N/A
Fax
N/A
Employees
56
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$970 thousand
Price / Sales
1,827.25
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
29,516,000
Free Float
N/A
Market Cap
$1.77 billion
Optionable
Not Optionable
Beta
N/A
7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

This page (NASDAQ:PAND) was last updated on 7/14/2025 by MarketBeat.com Staff
From Our Partners